Skip to main content

Table 2 Comparison of anthropometric analysis between baseline and 6 months, and comparison of absolute change from baseline between the two groups

From: Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Variable Non-EPA group (n = 53) EPA group (n = 54) P value
Baseline 6-month Baseline 6-month
Weight (kg) 67.8 ± 10.0 66.3 ± 9.9* 67.6 ± 11.2 66.4 ± 11.0* 0.97
 Absolute Δ −1.1 (−3.0, 0.0) −1.0 (−2.8, 0.0) 0.49
Body mass index (kg/m2) 25.4 ± 2.4 24.8 ± 2.4* 25.3 ± 2.9 24.8 ± 2.8* 0.90
 Absolute Δ −0.5 (−1.1, 0.0) −0.4 (−1.0, 0.0) 0.53
Systolic blood pressure (mmHg) 135.6 ± 15.0 133.0 ± 17.1 132.9 ± 19.5 129.7 ± 19.0 0.35
 Absolute Δ −3.0 (−13.0, 8.0) −3.0 (−10.0, 4.0) 0.89
Diastolic blood pressure (mmHg) 78.6 ± 9.8 77.5 ± 10.9 77.2 ± 11.7 76.3 ± 8.2 0.51
 Absolute Δ −2.0 (−7.0, 3.3) 0.0 (−7.0, 6.0) 0.63
  1. P values represent comparison of each values between groups at 6 months except for absolute Δ
  2. As for absolute Δ of each values, P values represent comparison between the two groups
  3. Values are presented as mean ± standard deviation or medians and interquartile ranges, as indicated
  4. * P < 0.001 vs baseline